Add BrightSurf on Google Email

The Colorado Center for Personalized Medicine highlighted as a leader in precision medicine in research and clinical care

The Colorado Center for Personalized Medicine has hit a major milestone of returning clinical genetic results to over 30,000 patients, making it a leader in providing personalized patient care. The center is also studying pharmacogenomics and providing results to guide drug selection and dosing.

SourceUniversity of Colorado Anschutz Medical Campus·JournalThe American Journal of Human Genetics·DateJan 4, 2024

Study demonstrates potency of synthetic antibiotic against serious chronic infections

A new synthetic antibiotic teixobactin has been shown to be highly effective against 'superbugs' such as MRSA and bacterial biofilms, which are associated with serious chronic infections. The study's findings provide promising hope for the development of new treatments against multidrug-resistant bacteria and biofilm-related infections.

SourceUniversity of Liverpool·JournalEuropean Journal of Medicinal Chemistry·DateJan 3, 2024

Scientists harness flower “super power” to pave the way for new drug treatments

Researchers at the University of Bath have created a novel bacterial system to mass-produce cyclic proteins and peptides, addressing a significant bottleneck in the development of new therapeutic treatments. By harnessing the natural cyclization process from the Oldenlandia flower, they improved heat and chemical stability, as well as ...

SourceUniversity of Bath·JournalJACS Au·TypeExperimental study·DateNov 28, 2023

Insilico Medicine and University of Cambridge present new approach to discover targets for Alzheimer’s and other diseases with protein phase separation

Researchers identified potential therapeutic targets for Alzheimer's disease and other conditions using a new approach combining AI-driven target identification with protein phase separation analysis. The study provides insights into the role of protein phase separation in human disease and its potential as a therapeutic target.

SourceInSilico Medicine·JournalProceedings of the National Academy of Sciences·DateSep 25, 2023

Mount Sinai scientists unlock secrets of red blood cell transporter, potentially paving the way for new drugs

Researchers at Mount Sinai identified the structure of a red blood cell transporter and how it interacts with drugs. They discovered novel compounds capable of blocking the transporter, potentially leading to new treatments for conditions like hemolytic anemias.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalNature Structural & Molecular Biology·TypeComputational simulation/modeling·DateSep 7, 2023

Game-changing potential for drug testing and cardiovascular disease treatments - Tiny Heart Model Carries Massive Implications

A miniature human heart model, approximately half a grain of rice in size, has been developed to transform drug testing and cardiovascular research. This self-paced, multi-chambered model provides real-time measurements of essential parameters, enabling unprecedented insights into heart function and diseases.

SourceThe Hebrew University of Jerusalem·JournalNature Biomedical Engineering·TypeExperimental study·DateAug 7, 2023

Gene therapy treats chronic pain by dialing down sodium

Researchers at NYU College of Dentistry developed a gene therapy that regulates sodium ion channel activity to alleviate chronic pain. By targeting the specific region where CRMP2 binds to NaV1.7, they were able to reduce sodium influx and quiet down neurons, providing relief from pain in cell and animal studies.

SourceNew York University·JournalProceedings of the National Academy of Sciences·DateJul 27, 2023

Insilico Medicine scientists propose stricter standards for evaluating generative AI-produced molecules

The study evaluates recent research on artificial intelligence-generated molecular structures from the perspective of medicinal chemists, recommending guidelines for assessing novelty and validity. Insilico Medicine's recommendations aim to improve the process of generating and evaluating novel AI-generated drugs.

SourceInSilico Medicine·JournalACS Medicinal Chemistry Letters·TypeLiterature review·DateJul 18, 2023

CT with CTA versus MRI in patients with dizziness

Using MRI instead of CT with CTA alone in patients presenting to the ED with dizziness was associated with greater critical neuroimaging results and more frequent echocardiography. Patients with dizziness undergoing MRI showed a lower frequency of 90-day ED readmissions compared to those discharged after CT with CTA alone.

SourceAmerican Roentgen Ray Society·JournalAmerican Journal of Roentgenology·TypeImaging analysis·DateJul 7, 2023

New venom discovery from deadly cone snails

Researchers discovered crucial differences in venoms across the lifecycle of cone snails, using a new laboratory aquarium system to study juvenile stages. The findings reveal unique adaptations for hunting and venom composition, offering potential new drugs for pain medication and disease treatment.

SourceUniversity of Queensland·JournalNature Communications·TypeObservational study·DateJun 27, 2023

New model offers a way to speed up drug discovery

Researchers have developed a new AI model that can quickly screen large libraries of potential drug compounds against target proteins. The ConPLex model uses language analysis to match potential drugs with proteins without needing to calculate molecular structures, enabling fast screening of over 100 million compounds per day.

SourceMassachusetts Institute of Technology·JournalProceedings of the National Academy of Sciences·DateJun 9, 2023

Using AI to create better, more potent medicines

Researchers at Ohio State University developed an AI framework called G2 Retro to automatically generate chemical reactions for molecules. The framework was shown to cover a vast range of possible reactions and accurately predict the best synthesis routes, offering more efficient drug design options.

SourceOhio State University·JournalCommunications Chemistry·TypeMeta-analysis·DateMay 30, 2023

Researchers overcome stem cell delivery barrier, paving the way for regenerative medicine

Scientists have developed a new method to deliver genetic information to stem cells using nanoparticles coated with a specific polymer, enabling more efficient control over cellular differentiation. This innovation has the potential to improve the efficiency and effectiveness of regenerative medicine treatments.

SourceXi'an Jiaotong-Liverpool University·JournalNano Letters·TypeExperimental study·DateMay 8, 2023

Birch reduction simplified to a one-minute mechanochemical process

Researchers at Hokkaido University have developed a simplified Birch reduction method that avoids liquid ammonia and can be carried out in ambient air, making it faster and more eco-friendly. The mechanochemical approach uses a ball mill to break through the surface layer on lithium metal, enabling the Birch reduction to proceed.

SourceHokkaido University·JournalAngewandte Chemie International Edition·TypeExperimental study·DateApr 7, 2023